New Clinical Trials For CONvid-1984 Bioweapons Hints Of “Fool Me Once”

“Fool me once, shame on you. Fool me twice, shame on me.” This 1600s euphemism, appearing in Anthony Weldon’s book The Court and Character of King James, should ring loud and clear with Americans when hearing CONvid-1984 modified mRNA gene therapy bioweapon shot manufacturers are “pledging” to conduct “fresh trials for the shots”.

Pfizer and BioNTech have committed to carrying out a randomized, double-blind, placebo-controlled trial to evaluate the safety and efficacy of their COVID-19 vaccine in adults aged 50 to 64 who do not have any conditions that are said to place them at increased risk for severe COVID-19, Dr. David Kaslow, an official with the Food and Drug Administration, said in one of the documents, an approval letter to the companies, dated Aug. 27.

Moderna has conveyed a written commitment to conduct a randomized, observer-blind, placebo-controlled study testing the safety of its two COVID-19 vaccines in the same population, Kaslow said in another letter, sent to the company.

Novavax has pledged to run a randomized, observer-blind, placebo-controlled trial in the same population “to evaluate the circulating vaccine-derived spike protein,” based on “a comprehensive symptom survey,” according to Kaslow’s letter to Novavax.

The Pfizer study is slated to be completed on July 31, 2026, according to the documents. The company will have until Jan. 31, 2027, to complete its final report on the trial.

Moderna’s trial is to end by Jan. 31, 2027, with a final report due one year later. Novavax’s trial is not slated to be finished until Nov. 30, 2027. Its final report is not due until May 31, 2028.

Are there individuals who would be gullible enough to participate in these trials after the debacle that occurred in 2020? Apparently so. It seems they didn’t learn from the 1600s euphemism. Who at this point would have any confidence in these manufacturers to conduct honest, reliable, transparent clinical trials? It seems Dr. Vinay Prasad, top “vaccine” official at the Food and Drug Administration (FDA), and the Department of Health and Human Services (HHS) have plenty of confidence that these manufacturers will “behave” appropriately. Why are these still being called “vaccines” by the very agencies and agency heads who know these shots are gene therapy bioweapons?

Being that these CONvid-1984 modified mRNA gene therapy bioweapons shots were a Department of Defense (DOD) military operation (see works of Sasha Latypova and Katherine Watt), disguised as a civilian public health initiative to combat a “pandemic”, how are “new” trials being conducted when it is considered unethical to conduct new trials on childhood vaccines already approved and on the market, according to Stanley Plotkin, Paul Offitt, and Kathryn Edwards?

Let’s look at what is being reported.

Pfizer and BioNTech committed to conducting a randomized, double-blind, placebo-controlled trial on its CONvid-1984 bioweapon shot to evaluate safety and efficacy in adults aged 50 to 64. Which of their products are they going to “trial” – the original, first, second, third, etc. booster? What “placebo” are they going to use? The FDA recognizes two types: placebo and inert placebo. An inert placebo would be normal saline, while a placebo could be anything, including another CONvid-1984 bioweapon shot.

The Pfizer and BioNTech study will be completed on July 31, 2026 – that is less than one year from now. When did that trial start? It’s slated to start September 30, 2025. Does anyone believe this timeframe is adequate to determine safety and efficacy? It’s a rinse and repeat of the original trial occurring in 2020.

Moderna committed to conducting a randomized, “observer-blind”, placebo-controlled trial to test “safety” to be completed on January 31, 2027. Interesting that efficacy is missing. Notice the “trial” is not double-blind, but “observer-blind”. An observer-blind study means the researchers do not know which participants received the study intervention or the placebo; but, the participants know what they received. That certainly does not meet any gold standard for clinical trials. The same issue with placebo exists with Moderna as Pfizer. Again, the timeframe is not long enough to adequately assess safety.

Novavax proposed to conduct a Phase 3 Open-Label Single-arm study to evaluate safety and immunogenicity of “an Omicron JN.1 subvariant SARS-COV-2 rS vaccine” to be completed July 31, 2026. This study begins October 14, 2025. According to the approval letter, the version tested will be Version 3.0, dated June 9, 2025. In this type of study, all the participants receive the same treatment or intervention with participants and researchers knowing who receives the treatment. There is no control group (placebo group) for comparison and investigators only observe this one group. Moreover, the “sample size” is smaller. This certainly misses the gold standard mark on multiple levels.

Novavax also proposed to conduct a “Phase IV, Observer-Blind, Placebo-controlled, Randomized Clinical Trial to Evaluate the Circulating Vaccine-derived Spike Protein in Adults 50 – 64 years of age with no history of PCVS or Long COVID, as Based on a Comprehensive Symptom Survey” with an initiation date of November 30, 2026, and a slotted completion date of November 30, 2027. There should be no need for further evaluation after the previous analysis of the other “clinical trials”.

Prasad indicated that encouraging the companies to conduct randomized clinical trials would help “regulators determine if the benefits of the vaccines outweigh the risks in younger, healthy individuals”.

“FDA has a statutory mandate to only approve products when we have substantial certainty benefits outweigh harms and, in cases when we do not, sponsors are free to prove to the agency and the American people the worth of their products with randomized trials,” he said in one memo.

According to the initial approval letters at the FDA for all the CONvid-1984 modified mRNA gene therapy bioweapon shots, the letters indicated the FDA “believed” the benefits outweighed the harms, “believed” the bioweapon shots were safe, and “believed” the bioweapon shots were effective. Now, belief has changed to “substantial certainty”, which is still “belief”. Moreover, all these products were manufactured under the PREP Act as a DOD military operation, meaning there was no civilian authority involvement when meeting FDA statutory mandates. The pharmaceutical companies basically admitted it. Paraphrasing their rationale – “we were asked to make a prototype and we did”. The PREP Act does not require clinical trials or any FDA, Center for Disease Control (CDC), or other entity approval.

“There is growing clinical evidence that spike protein, which is generated as a result of or in the course of vaccination, may persist for some time in a subset of individuals,” while the symptoms of so-called long COVID are “ill-defined but concern many Americans,” and some believe the two are linked, Prasad said in another memo. The FDA is thus requesting the companies “generate information which may link or exculpate any such relationship,” he said.

The studies could also show that the vaccines reduce symptoms of long COVID, Prasad added later.

Well, butter my butt and call me a biscuit. It’s more gaslighting from different players in the same game. It’s shameful. The pharma manufacturers are not going to shoot their golden calf in the head and destroy their bottom line or shoot themselves in the foot and expose their liability for injury and death, despite having illegal impunity. No unconstitutional agency nor anyone in it will ever admit an “oops” occurred with the CONvid-1984 modified mRNA gene therapy bioweapon shots. Can it really be called an “oops”? Afterall, the military obtained an effective bioweapon masquerading as a health intervention.

Unfortunately, the “vaccine” cultists will flock to enroll in these clinical trials without any thought to possible injury, harm, or death. They will not remember Maddie DeGaray, Brianne Dressen, or the numerous other individuals injured or dead because of these bioweapon shots, nor will they think about all the lost babies from giving these bioweapons to pregnant women. After all, they will rationalize that it is for the greater good. In this type of cultist ideology, death is justified for the greater good. The real question is how many people have to be injured or dead before the sacrifice for the greater good cannot be justified – 100; 1,000; 10,000; 100,000? With an alleged 17 million dead worldwide from these bioweapon shots or 0.24 % of the population (it’s possible that the number is higher), how many more have to suffer or die before these shots are totally ceased? The loss of 17 million people worldwide is akin to losing almost the entire population of New York State or the States of Georgia and Indiana.

It won’t be just the “vaccine” cultists that will line up to get a stab in the arm in these clinical trials. You will see plenty of RFK Jr. sycophants and blind allegiance followers ready to participate. “Bobby’s got their back”, after all. “He’s out to make Americans healthy again and needs the support because of all the people attacking him when he’s trying to fight for us”.

At this point, no one can say “I didn’t know”. Anyone volunteering for these trials certainly has not learned a valuable lesson and will be on their own should harm befall them. It happened in round one, and is sure to occur in round two.

Article posted with permission from Sons of Liberty Media

The post New Clinical Trials For CONvid-1984 Bioweapons Hints Of “Fool Me Once” appeared first on The Washington Standard.